Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 (original) (raw)

Nature volume 442, pages 916–919 (2006)Cite this article

Abstract

Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years1. A large proportion of FTD patients (35–50%) have a family history of dementia, consistent with a strong genetic component to the disease2. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17)3. The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau3,4. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787–D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology5,6,7,8,9,10,11,12. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions11,12,13. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation14. PGRN has also been strongly linked to tumorigenesis14. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt–Jakob disease, motor neuron disease and Alzheimer's disease15,16. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Brun, A. et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J. Neurol. Neurosurg. Psychiatry 57, 416–418 (1994)
    Article Google Scholar
  2. Chow, T. W., Miller, B. L., Hayashi, V. N. & Geschwind, D. H. Inheritance of frontotemporal dementia. Arch. Neurol. 56, 817–822 (1999)
    Article CAS Google Scholar
  3. Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705 (1998)
    Article ADS CAS Google Scholar
  4. Ingram, E. M. & Spillantini, M. G. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8, 555–562 (2002)
    Article CAS Google Scholar
  5. Rademakers, R. et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol. Psychiatry 7, 1064–1074 (2002)
    Article CAS Google Scholar
  6. Rosso, S. M. et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21–22. Brain 124, 1948–1957 (2001)
    Article CAS Google Scholar
  7. Lendon, C. L. et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21–22. Neurology 50, 1546–1555 (1998)
    Article CAS Google Scholar
  8. Kertesz, A. et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54, 818–827 (2000)
    Article CAS Google Scholar
  9. Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997)
    Article CAS Google Scholar
  10. Bird, T. D. et al. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 48, 949–954 (1997)
    Article CAS Google Scholar
  11. van der Zee, J. et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129, 841–852 (2006)
    Article Google Scholar
  12. Mackenzie, I. R. et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129, 853–867 (2006)
    Article Google Scholar
  13. Rademakers, R. et al. In IPSEN Meeting Research and Perspectives in Alzheimer's Disease: Genotype–Proteotype–Phenotype Relationships in Neurodegenerative Diseases (ed. Cummings, J.) 117–137 (Springer, Paris, 2005)
    Google Scholar
  14. He, Z. & Bateman, A. Progranulin (granulin–epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. 81, 600–612 (2003)
    Article CAS Google Scholar
  15. Malaspina, A., Kaushik, N. & de Belleroche, J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132–145 (2001)
    Article CAS Google Scholar
  16. Baker, C. A. & Manuelidis, L. Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease. Proc. Natl Acad. Sci. USA 100, 675–679 (2003)
    Article ADS CAS Google Scholar
  17. Neary, D., Snowden, J. S. & Mann, D. M. Classification and description of frontotemporal dementias. Ann. NY Acad. Sci. 920, 46–51 (2000)
    Article ADS CAS Google Scholar
  18. Trojanowski, J. Q. & Dickson, D. Update on the neuropathological diagnosis of frontotemporal dementias. J. Neuropathol. Exp. Neurol. 60, 1123–1126 (2001)
    Article CAS Google Scholar
  19. Mackenzie, I. R. & Feldman, H. H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J. Neuropathol. Exp. Neurol. 64, 730–739 (2005)
    Article Google Scholar
  20. Foster, N. L. et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41, 706–715 (1997)
    Article CAS Google Scholar
  21. Mackenzie, I. R. & Feldman, H. Neuronal intranuclear inclusions distinguish familial FTD–MND type from sporadic cases. Acta Neuropathol. (Berl.) 105, 543–548 (2003)
    Google Scholar
  22. Cruts, M. et al. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. Hum. Mol. Genet. 14, 1753–1762 (2005)
    Article CAS Google Scholar
  23. Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature advance online publication, doi:10.1038/nature05017 (16 July 2006)
  24. Maquat, L. E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5, 89–99 (2004)
    Article CAS Google Scholar
  25. Daniel, R., He, Z., Carmichael, K. P., Halper, J. & Bateman, A. Cellular localization of gene expression for progranulin. J. Histochem. Cytochem. 48, 999–1009 (2000)
    Article CAS Google Scholar
  26. Capsoni, S. et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl Acad. Sci. USA 97, 6826–6831 (2000)
    Article ADS CAS Google Scholar
  27. Salehi, A., Delcroix, J. D. & Swaab, D. F. Alzheimer's disease and NGF signaling. J. Neural Transm. 111, 323–345 (2004)
    Article CAS Google Scholar
  28. Lu, R. & Serrero, G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc. Natl Acad. Sci. USA 98, 142–147 (2001)
    Article ADS CAS Google Scholar
  29. Tangkeangsirisin, W. & Serrero, G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25, 1587–1592 (2004)
    Article CAS Google Scholar
  30. Greenway, M. J. et al. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nature Genet. 38, 411–413 (2006)
    Article CAS Google Scholar
  31. He, Z., Ong, C. H., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nature Med. 9, 225–229 (2003)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank the FTD research team at Vancouver Coastal Health and the University of British Columbia, and particularly G. Y. R. Hsiung, for identification and follow-up of FTD families; D. Warden, P. Whitbread and E. King (OPTIMA project, Oxford, UK) for assisting with collection of UBC17 family samples; J. Chow (Department of Pathology, University of British Columbia) for help in performing the PGRN immunohistochemistry; and M. Yue, J. Gonzales (Mayo Clinic), T. de Pooter and M. Van den Broeck (University of Antwerp) for technical support. This research was funded as part of the Mayo Clinic ADRC grant from the National Institute on Aging (to M.H.), the Mayo Foundation (M.H.), and the Robert and Clarice Smith Fellowship program (to S.M.). I.R.M. and H.F. were funded by the Canadian Institutes of Health research operating grant. S.M.P.-B. received grants from the Medical Research Council (UK) and the Motor Neuron Disease Association. R.R. is a postdoctoral fellow of the Fund for Scientific Research Flanders and a visiting scientist from the Neurodegenerative Brain Diseases Group of the Department of Molecular Genetics, VIB, University of Antwerp, Belgium. Finally, we acknowledge and thank the families who contributed samples, as without them this study would not have been possible.

Author information

Author notes

  1. Matt Baker, Ian R. Mackenzie and Stuart M. Pickering-Brown: *These authors contributed equally to this work

Authors and Affiliations

  1. Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Florida, 32224, Jacksonville, USA
    Matt Baker, Jennifer Gass, Rosa Rademakers, Jennifer Adamson, Ashley Cannon, Stacey Melquist, Dennis Dickson, Zdenek Berger, Jason Eriksen, Todd Robinson, Cynthia Zehr, Chad A. Dickey, Richard Crook, Eileen McGowan & Mike Hutton
  2. Department of Pathology,
    Ian R. Mackenzie
  3. Division of Neurology,
    Caroline Lindholm, A. Dessa Sadovnick & Howard Feldman
  4. Department of Medical Genetics, University of British Columbia, 2211 Wesbrook Mall, V6T 2B5, British Columbia, Vancouver, Canada
    A. Dessa Sadovnick & Emily Dwosh
  5. Division of Laboratory and Regenerative Medicine, Department of Medicine, University of Manchester, Oxford Road, M13 9PT, Manchester, UK
    Stuart M. Pickering-Brown & Sara Rollinson
  6. Centre for Clinical Neurosciences, University of Manchester, Greater Manchester Neurosciences Centre, Hope Hospital, M6 8HD, Salford, UK
    Stuart M. Pickering-Brown, Julie Snowden, David Neary, Anna Richardson & David Mann
  7. Department of Neurology, Mayo Clinic College of Medicine, Minnesota, 55905, Rochester, USA
    Bradley Boeve

Authors

  1. Matt Baker
    You can also search for this author inPubMed Google Scholar
  2. Ian R. Mackenzie
    You can also search for this author inPubMed Google Scholar
  3. Stuart M. Pickering-Brown
    You can also search for this author inPubMed Google Scholar
  4. Jennifer Gass
    You can also search for this author inPubMed Google Scholar
  5. Rosa Rademakers
    You can also search for this author inPubMed Google Scholar
  6. Caroline Lindholm
    You can also search for this author inPubMed Google Scholar
  7. Julie Snowden
    You can also search for this author inPubMed Google Scholar
  8. Jennifer Adamson
    You can also search for this author inPubMed Google Scholar
  9. A. Dessa Sadovnick
    You can also search for this author inPubMed Google Scholar
  10. Sara Rollinson
    You can also search for this author inPubMed Google Scholar
  11. Ashley Cannon
    You can also search for this author inPubMed Google Scholar
  12. Emily Dwosh
    You can also search for this author inPubMed Google Scholar
  13. David Neary
    You can also search for this author inPubMed Google Scholar
  14. Stacey Melquist
    You can also search for this author inPubMed Google Scholar
  15. Anna Richardson
    You can also search for this author inPubMed Google Scholar
  16. Dennis Dickson
    You can also search for this author inPubMed Google Scholar
  17. Zdenek Berger
    You can also search for this author inPubMed Google Scholar
  18. Jason Eriksen
    You can also search for this author inPubMed Google Scholar
  19. Todd Robinson
    You can also search for this author inPubMed Google Scholar
  20. Cynthia Zehr
    You can also search for this author inPubMed Google Scholar
  21. Chad A. Dickey
    You can also search for this author inPubMed Google Scholar
  22. Richard Crook
    You can also search for this author inPubMed Google Scholar
  23. Eileen McGowan
    You can also search for this author inPubMed Google Scholar
  24. David Mann
    You can also search for this author inPubMed Google Scholar
  25. Bradley Boeve
    You can also search for this author inPubMed Google Scholar
  26. Howard Feldman
    You can also search for this author inPubMed Google Scholar
  27. Mike Hutton
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toIan R. Mackenzie or Mike Hutton.

Ethics declarations

Competing interests

Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Notes

This file contains Supplementary Methods, Supplementary Table 1 and Supplementary Figures 1–4. (PDF 2631 kb)

Rights and permissions

About this article

Cite this article

Baker, M., Mackenzie, I., Pickering-Brown, S. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.Nature 442, 916–919 (2006). https://doi.org/10.1038/nature05016

Download citation

This article is cited by

Editorial Summary

Dementia-causing mutation

Two groups of neuroscientists have discovered that a mutation in the progranulin gene, which encodes a growth factor, can cause frontotemporal dementia (FTD). The condition, the second most common form of dementia among under-65s, impairs memory and personality and may also affect movement. The discovery may help to resolve confusion over the cause of the disease — mutations in a neighbouring gene called microtubule-associated protein tau were shown previously to be associated with some, but not all, cases of FTD.